The present invention relates to compositions and methods relating to the characterization
and function of CYT28. Specifically, the present invention provides transgenic
animals comprising disruptions in a CYT28 gene and methods of treating diseases
conditions, such as pain. The present invention further relates to agents that
modulate CYT28 and methods of screening for agents that modulate CYT28 for the
treatment of diseases and conditions such as pain.